TILT Holdings (TLLTF) Amortizatization of Intangibles (2021 - 2025)
TILT Holdings (TLLTF) reported Amortizatization of Intangibles of $619000.0 for Q2 2025, little changed on a YoY basis from $616000.0 in Q2 2024, and down 11.19% quarter-over-quarter from $697000.0 in Q1 2025.
TILT Holdings (TLLTF) Amortizatization of Intangibles (2021 - 2025) Analysis & Trends
TILT Holdings has reported Amortizatization of Intangibles for 5 years, with the latest figure at $619000.0 in Q2 2025.
- For the quarter ending Q2 2025, Amortizatization of Intangibles changed 0.49% year-over-year to $619000.0; the trailing twelve-month figure through Jun 2025 stood at $1.8 million (down 27.66% YoY), and the FY2024 full-year result was $1.8 million, down 23.22% from the prior year.
- Amortizatization of Intangibles for Q2 2025 stood at $619000.0, down from $697000.0 in the prior quarter.
- The five-year high for Amortizatization of Intangibles was $2.0 million in Q4 2022, with the low at -$1.0 million in Q3 2022.
- Historically, Amortizatization of Intangibles has averaged $588000.0 across 5 years, with a median of $658000.0 in 2025.
- Annual changes were most pronounced in 2022 — Amortizatization of Intangibles jumped 839.91% — and 2024, when it sank 189.0%.
- TILT Holdings' Amortizatization of Intangibles stood at $218000.0 in 2021, then jumped by 839.91% to $2.0 million in 2022, then tumbled by 80.48% to $400000.0 in 2023, then slumped by 189.0% to -$356000.0 in 2024, then soared by 273.88% to $619000.0 in 2025.
- The last three Amortizatization of Intangibles figures came in at $619000.0 (Q2 2025), $697000.0 (Q1 2025), and -$356000.0 (Q4 2024), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Amortizatization of Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 38.77 Bn | 35.04 Bn | 1.97 Bn | - |
| 2 | Zoetis | 34.11 Bn | 32.16 Bn | 1.62 Bn | - |
| 3 | United Therapeutics | 23.68 Bn | 21.53 Bn | 648.10 Mn | - |
| 4 | Aurora Cannabis | 16.48 Bn | 16.40 Bn | 33.43 Mn | - |
| 5 | Neurocrine Biosciences | 16.19 Bn | 14.88 Bn | 800.70 Mn | 1.30 Mn |
| 6 | Elanco Animal Health | 11.44 Bn | 11.01 Bn | 785.00 Mn | - |
| 7 | Alkermes | 7.28 Bn | 6.77 Bn | -116.06 Mn | - |
| 8 | Lantheus Holdings | 6.48 Bn | 5.98 Bn | 230.92 Mn | - |
| 9 | Hims & Hers Health | 6.35 Bn | 5.60 Bn | 396.79 Mn | 242,000.00 |
| 10 | TILT Holdings | - | - | 1.82 Mn | 619,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2025 | 619,000.00 |
| Jun 30, 2025 | 619,000.00 |
| Mar 31, 2025 | 697,000.00 |
| Mar 31, 2025 | 697,000.00 |
| Dec 31, 2024 | -356,000.00 |
| Dec 31, 2024 | -356,000.00 |
| Sep 30, 2024 | 792,000.00 |
| Sep 30, 2024 | 792,000.00 |
| Jun 30, 2024 | 616,000.00 |
| Jun 30, 2024 | 616,000.00 |
| Mar 31, 2024 | 704,000.00 |
| Mar 31, 2024 | 704,000.00 |
| Dec 31, 2023 | 400,000.00 |
| Dec 31, 2023 | 400,000.00 |
| Sep 30, 2023 | 702,000.00 |
| Sep 30, 2023 | 702,000.00 |
| Jun 30, 2023 | 701,000.00 |
| Jun 30, 2023 | 701,000.00 |
| Mar 31, 2023 | 484,000.00 |
| Mar 31, 2023 | 484,000.00 |